Responses
Clinical/translational cancer immunotherapy
Original research
Combination of cancer vaccine with CD122-biased IL-2/anti-IL-2 Ab complex shapes the stem-like effector NK and CD8+ T cells against tumor
Compose a Response to This Article
Other responses
No responses have been published for this article.